Catalent Completes Tender Offer for All Outstanding Shares of Juniper Pharmaceuticals, Inc.
About
Juniper Pharmaceuticals™ is a trademark of
About
More products. Better treatments. Reliably supplied.™
Cautionary Note Concerning Forward-Looking Statements
This release contains both historical and forward-looking statements, including concerning the tender offer for and merger with Juniper. These forward-looking statements generally can be identified because they relate to the topics set forth above or by the use of statements that include phrases such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “plan,” “project,” “foresee,” “likely,” “may,” “will,” “would” or other words or phrases with similar meanings. Similarly, statements that describe Catalent’s objectives, plans or goals are, or may be, forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Catalent’s expectations and projections. Some of the factors that could cause actual results to differ include, but are not limited to, the following: litigation relating to the transaction; other unanticipated events may make it more difficult to realize the anticipated benefits of the transaction; participation in a highly competitive market and increased competition may adversely affect the business of
View source version on businesswire.com: https://www.businesswire.com/news/home/20180814005207/en/
Media:
[email protected]
or
NEPR
[email protected]
or
Investors:
[email protected]
Source:
Nursing home could recoup $270,000 in claims
Governor surveys hurricane recovery efforts in Robeson, Columbus counties
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News